Itaconate drives mtRNA-mediated type I interferon production through inhibition of succinate dehydrogenase
Shane M. O’Carroll(Trinity College Dublin), Luke O'neill(Trinity College Dublin)
Cited by 43
Related Papers
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
|Cell Research|2015|1.8k
Targeting Toll-like receptors: emerging therapeutics?
|Nature Reviews Drug Discovery|2010|883
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
|Cell Metabolism|2020|571
Targeting immunometabolism as an anti-inflammatory strategy
|Cell Research|2020|552